Pigment epithelium-derived factor in ulcerative colitis: Possible relationship with disease activity

Regulatory Peptides

Volumn 140, Issue 1-2, 2007, Pages 1-4

  Wiercinska Drapalo, Alicja ^a   Jaroszewicz, Jerzy ^a   Parfieniuk, Anna ^a   Lapinski, Tadeusz Wojciech ^a   Rogalska, Magdalena ^a   Prokopowicz, Danuta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Angiogenesis; Pigment epithelium derived factor; Ulcerative colitis; Vascular endothelial growth factor

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENDOSCOPY; FEMALE; HUMAN; INTESTINE MUCOSA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ADULT; AGED; ANGIOGENESIS INHIBITORS; COLITIS, ULCERATIVE; EYE PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847059656     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.11.006     Document Type: Article

References (32)

1. Beck P.L., and Podolsky D.K. Growth factors in inflammatory bowel diseases. Inflamm Bowel Dis 5 (1999) 44-60
2. Kanazawa S., Tsunoda T., Onuma E., Majima T., Kagiyama M., and Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 96 (2001) 822-828
3. Danese S., Sans M., de la Motte C., Graziani C., West G., Phillips M.H., Pola R., Rutella S., Willis J., Gasbarrini A., and Fiocchi C. Gastroenterology 130 (2006) 2060-2073
4. Dawson D.W., Volpert O.V., and Gillis P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 5425 (1999) 245-248
5. Tombran-Tink J., and Johnson L.V. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Visual Sci 30 (1989) 1700-1707
6. Tombran-Tink J. The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling. Front Biosci 10 (2005) 2131-2149
7. Tombran-Tink J., Lara N., Apricio S.E., Potluri P., Gee S., Ma J.X., Chader G., and Barnstable C.J. Retinoic acid and dexamethasone regulate the expression of PEDF in retinal and endothelial cells. Exp Eye Res 78 (2004) 945-955
8. Abe R., Shimizu T., Yamagishi S., Shibaki A., Amano S., Inagaki Y., Watanabe H., Sugawara H., Nakamura H., Takeuchi M., Imaizumi T., and Shimizu H. Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 164 (2004) 1225-1232
9. Zhang S.X., Wang J.J., Gao G., Shao C., Mott R., and Ma J.X. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 20 (2006) 323-325
10. Ek E.T., Dass C.R., and Choong P.F. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med 12 (2006) 497-502
11. Ek E.T., Dass C.R., and Choong P.F. Pigment epithelium-derived factor: a multimodal tumor inhibitor. Mol Cancer Ther 5 (2006) 1641-1646
12. Yamagishi S., Adachi H., Abe A., Yashiro T., Enomoto M., Furuki K., Hino A., Jinnouchi Y., Takenaka K., Matsui T., Nakamura K., and Imaizumi T. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 91 (2006) 2447-2450
13. Abramson L.P., Stellmach V., and Doll J.A. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. J Pediatr Surg 38 (2003) 336-342
14. Ranieri G., Ria R., and Roccaro A.M. Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases. Curr Drug Targets Inflamm Allergy 4 (2005) 13-22
15. Mori K., Gehlbach P., Ando A., McVey D., Wei L., and Campochiaro P.A. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Visual Sci 43 (2002) 2428-2434
16. Dieckgraefe B.K., Stenson W.F., Korzenik J.R., Swanson P.E., and Harrington C.A. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 4 (2000) 1-11
17. Griga T., Hebler U., Voigt E., Tromm A., and May B. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Hepatogastroenterology 47 (2000) 1604-1607
18. Bulut K., Pennartz C., Felderbauer P., Ansorge N., Banasch M., Schmitz F., Schmidt W.E., and Hoffmann P. Vascular endothelial growth factor (VEGF164) ameliorates intestinal epithelial injury in vitro in IEC-18 and Caco-2 monolayers via induction of TGF-beta release from epithelial cells. Scand J Gastroenterol 41 (2006) 687-692
19. Meyers S., Sachar D.B., Present D.H., and Janowitz H.D. Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo controlled double blind, dose-ranging clinical trial. Scand J Gastroenterol 23 Suppl 148 (1988) 29-35
20. Hatoum O.A., Binion D.G., and Gutterman D.D. Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Investig 35 (2005) 599-609
21. Saito S., Tsuno N.H., Sunami E., Hori N., Kitayama J., Kazama S., Okaji Y., Kawai K., Kanazawa T., Watanabe T., Shibata Y., and Nagawa H. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. J Gastroenterol 38 3 (2003) 229-237
22. Konno S., Iizuka M., Yukawa M., Sasaki K., Sato A., Horie Y., Nanjo H., Fukushima T., and Watanabe S. Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease. J Gastroenterol 39 (2004) 931-939
23. Ido A., Numata M., Kodama M., and Tsubouchi H. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J Gastroenterol 40 (2005) 925-931
24. Deng X., Szabo S., Khomenko T., Jadus M.R., and Yoshida M. Gene therapy with adenoviral plasmids or naked DNA of vascular endothelial growth factor and platelet-derived growth factor accelerates healing of duodenal ulcer in rats. J Pharmacol Exp Ther 311 (2004) 982-988
25. Sandor Z., Deng X.M., Khomenko T., Tarnawski A.S., and Szabo S. Altered angiogenic balance in ulcerative colitis: a key to impaired healing?. Biochem Biophys Res Commun 350 (2006) 147-150
26. Volpert O.V., Zaichuk T., Zhou W., Reiher F., Ferguson T.A., Stuart P.M., Amin M., and Bouck N.P. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 8 (2002) 349-357
27. Cai J., Jiang W.G., Grant M.B., and Boulton M. Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281 (2006) 3604-3613
28. Zhang S.X., Wang J.J., Gao G., Parke K., and Ma J.X. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol 37 (2006) 1-12
29. Becker C., Fantini M.C., and Neurath M.F. TGF-beta as a T cell regulator in colitis and colon cancer. Cytokine Growth Factor Rev 17 (2006) 97-106
30. Wiercinska-Drapalo A., Flisiak R., and Prokopowicz D. Effect of ulcerative colitis treatment on transforming growth factor beta(1) in plasma and rectal mucosa. Regulatory Pept 113 (2003) 57-61
31. Wang J.J., Zhang S.X., Lu K., Chen Y., Mott R., Sato S., and Ma J.X. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy. Diabetes 54 (2005) 243-250
32. Yamagishi S., Inagaki Y., Nakamura K., Abe R., Shimizu T., Yoshimura A., and Imaizumi T. Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J Mol Cell Cardiol 37 (2004) 497-506